Unsubstituted Phenols
Medchemexpress LLC HY-17630 5mg Medchemexpress, Edasalonexent CAS:1204317-86-1 Purity:>98%
Medchemexpress, HY-17630 5mg Edasalonexent CAS:1204317-86-1 Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
![eMolecules Medchem Express / ()-PD 128907 hydrochloride / 5mg / 437899086 / HY-110000 / / 300576-59-4 / [null] / 285.770 / C14H20ClNO3](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502453317.PNG-250.jpg)
eMolecules Medchem Express / ()-PD 128907 hydrochloride / 5mg / 437899086 / HY-110000 / / 300576-59-4 / [null] / 285.770 / C14H20ClNO3
Medchem Express / ()-PD 128907 hydrochloride / 5mg / 437899086 / HY-110000 / / 300576-59-4 / [null] / 285.770 / C14H20ClNO3
Apexbio Technology LLC Ko 143 461054-93-3 25mg
Ko 143 (CAS 461054-93-3) is a selective inhibitor of the breast cancer resistance protein (BCRP/ABCG2) an ATP-binding cassette transporter implicated in multidrug resistance in cancer cells By targeting BCRP Ko 143 effectively blocks BCRP-mediated drug efflux as demonstrated by an EC90 of 26 nM in cell-based assays This compound exhibits over 200-fold selectivity for BCRP compared to P-glycoprotein and MRP1 In vitro Ko 143 reverses BCRP-mediated resistance to chemotherapeutics such as topotecan and mitoxantrone enhancing their potency up to tenfold in relevant cancer cell lines Ko 143 has been used in murine models to increase systemic exposure of BCRP substrates supporting its utility in studying drug resistance mechanisms and improving chemotherapeutic efficacy in preclinical research
Apexbio Technology LLC Ko 143 461054-93-3 10mg
Ko 143 (CAS 461054-93-3) is a selective inhibitor of the breast cancer resistance protein (BCRP/ABCG2) an ATP-binding cassette transporter implicated in multidrug resistance in cancer cells By targeting BCRP Ko 143 effectively blocks BCRP-mediated drug efflux as demonstrated by an EC90 of 26 nM in cell-based assays This compound exhibits over 200-fold selectivity for BCRP compared to P-glycoprotein and MRP1 In vitro Ko 143 reverses BCRP-mediated resistance to chemotherapeutics such as topotecan and mitoxantrone enhancing their potency up to tenfold in relevant cancer cell lines Ko 143 has been used in murine models to increase systemic exposure of BCRP substrates supporting its utility in studying drug resistance mechanisms and improving chemotherapeutic efficacy in preclinical research
Hampton Research DETERGENT SCREEN 44(D08)0.5 ML
Detergent Screen 44 (D08) 0.5 mL195.0 mM Methyl-6-O-(N-heptylcarbamoyl)-a-D-glucopyranoside
Selleck Chemical LLC 2 4-Dihydroxybenzoic acid
2 4-Dihydroxybenzoic acid ( -resorcylic acid p-Hydroxysalicylic acid) is a degradation product of cyanidin glycosides from tart cherries in cell cultures and a metabolite found in human plasma after cranberry juice consumption
eMolecules Ambeed / 4-Hydroxyphenylacetic Acid / 100g / 552528940 / A109495 / / 156-38-7 / MFCD00004347 / 152.149 / C8H8O3
Ambeed / 4-Hydroxyphenylacetic Acid / 100g / 552528940 / A109495 / / 156-38-7 / MFCD00004347 / 152.149 / C8H8O3
Medchemexpress LLC Combretastatin A-1 | 109971-63-3 | >98.0% | 50 MG
Combretastatin A-1 is a cis-stilbene microtubule polymerization inhibitor (CAS 109971-63-3) used in research to study tubulin dynamics and as an experimental antitumor agent. It is supplied as a crystalline solid for research use and is typically handled and stored under cold conditions to preserve stability.
- Microtubule polymerization inhibitor that binds the colchicine site on tubulin.
- Used for cellular assays and in vivo cancer research models.
- Crystalline solid; typically stored at -20°C for long-term stability.
- Molecular weight 332.4 g/mol, chemical formula C18H20O6.
- Provided in research-scale quantities suitable for assay development and preclinical studies.
Medchemexpress LLC HY-16950 50mg , 4-Hydroxytamoxifen (Z)-4-Hydroxytamoxifen;trans-4-Hydroxytamoxifen CAS:68047-06-3 Purity:98%
Medchemexpress, HY-16950 50mg 4-Hydroxytamoxifen (Z)-4-Hydroxytamoxifen;trans-4-Hydroxytamoxifen CAS:68047-06-3 Formula:C26H29NO2 IC50: 3.3 nM (Oestrogen receptor) CRISPR/Cas9 Purity:98% 4-Hydroxytamoxifen, an active metabolite of tamoxifen, is a selective estrogen receptor antagonist, with an IC 50 of 3.3 nM for the [ 3 H]oestradiol binding to oestrogen receptor, widely used to treat breast cancer; 4-Hydroxytamoxifen also increases CRISPR/Cas9 -mediated editing frequency. Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
eMolecules BENZYL (3-HYDROXYBENZYL)CARBAMATE | 75383-61-8 | MFCD14585006 | 1g
AstaTech | BENZYL (3-HYDROXYBENZYL)CARBAMATE | 1g | 451913878 | S10323 | 95.000 | 75383-61-8 | MFCD14585006 | 257.289 | C15H15NO3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules Medchem Express / I-OMe-Tyrphostin AG 538 / 5mg / 686921802 / HY-135680 / / 1094048-77-7 / MFCD03453582 / 437.189 / C17H12INO5
Medchem Express / I-OMe-Tyrphostin AG 538 / 5mg / 686921802 / HY-135680 / / 1094048-77-7 / MFCD03453582 / 437.189 / C17H12INO5
Apexbio Technology LLC Phenol Red sodium salt 34487-61-1 5g
Phenol Red sodium salt (34487-61-1) is a small molecule compound binding to estrogen receptors It can interact with estrogen receptors thereby modulating downstream signaling pathways and associated cellular processes Phenol Red sodium salt functions primarily via estrogen receptor affinity In cell-based studies it binds to estrogen receptors in human breast cancer cell lines such as MCF-7 cells Based on these properties Phenol Red sodium salt holds research potential in oncology studies particularly those investigating hormone-mediated signaling pathways and receptor-mediated cellular responses